About this item
Product details
Diampa-M XR is a dual-combination, extended-release oral medication for the management of type 2 diabetes in adults. It combines Empagliflozin (an SGLT2 inhibitor) at a 12.5mg dose with a high 1000mg dose of Metformin in an extended-release (XR) formulation. This combination offers complementary mechanisms: Empagliflozin removes excess glucose through urine and provides cardiovascular/renal benefits, while Metformin XR reduces liver glucose production and improves insulin sensitivity with fewer gastrointestinal side effects due to its slow release. Dual-Action Glucose Control: Effectively lowers blood sugar through two distinct and powerful mechanisms. Extended-Release Metformin: Provides sustained 24-hour action with potentially better gastrointestinal tolerability. Cardiovascular & Kidney Protection: Empagliflozin offers proven benefits for heart and kidney health in patients with type 2 diabetes. Weight Management Support: May aid in weight loss or prevent weight gain, unlike some other diabetes medications. Composition Each Extended Release tablet contains: Empagliflozin: 12.5 mg Metformin HCI USP: 1000 mg Directions for Use As directed by the physician.
- Medicines
- 14 Extended Release Tablets
- 1 variant
- Protected Dastak checkout
Know before you buy
Specifications
- Department
- Health
- Subcategory
- Medicines
- Brand
- Getz Pharma
- SKU
- 8964002869312
- Variant
- 14 Extended Release Tablets
- Tags
- Empagliflozin, Medicine, Metformin
- Condition
- New
Customer feedback
Ratings & reviews
For help with a purchase, open your orders or contact Dastak support.
